Back to search

Netherlands· NL-c3f8627b8d7d

Erytromycine Eureco-Pharma i.v. 1 g poeder voor oplossing voor infusie

A erythromycin product containing erytromycinelactobionaat, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC J01FA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedErytromycine Eureco-Pharma i.v. 1 g p…ATCJ01FA01REGISTER NO.NL-c3f8627b8d7dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Erythromycin is registered in 13 of 19 countries.

Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Erythromycin · ATC J01FA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ERYTROMYCINELACTOBIONAAT
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
J01FA01
ATC class
Erythromycin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    126741//01800

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1011 interactions on record for erythromycin.

Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erythromycin · interactions on record

1011 records

  • 216 severe
  • 424 moderate
  • 70 minor
  • 227 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythromycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Belgium · Erycine, Erythrocine
  • Cyprus · Ermyced, Ermycin
  • Czechia · Aknemycin
  • Germany · Aknemycin, Erythromycin Panpharma
  • Denmark · Abboticin, Erythromycin Panpharma
  • Spain · Eritromicina Panpharma, Oftalmolosa Cusí Eritromicina
  • Finland · Abboticin, Abboticin Novum
  • France · Ery, Ery Nourrissons
  • United Kingdom (Northern Ireland) · Erythrocin 250, Erythrocin 500
  • Greece · Acne Hermal, Dankit
  • Croatia · Eritromicin Belupo
  • Hungary · Aknemycin
  • Ireland · Erythrocin
  • Italy · Eritromicina Idi
  • Lithuania · Erythromycin Tc
  • Luxembourg · Aknemycin, Ery
  • Latvia · Erythromycin Tzf
  • Norway · Abboticin, Ery-Max
  • Poland · Aknemycin, Cusi
  • Portugal · Akne-Mycin, Clinac
  • Romania · Eritromicină Atb
  • Sweden · Abboticin, Abboticin Novum
  • Slovakia · Aknemycin, Aknemycin 2000

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0b056a9b-82d9-45f3-9c67-5288c55d74b7
GET /v1/drugs/0b056a9b-82d9-45f3-9c67-5288c55d74b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h01800_smpc.pdf",
  "strength": null,
  "atc_label": "Erythromycin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126741",
  "excipients": [
    "GEEN HULPSTOFFEN"
  ],
  "substances": [
    "ERYTROMYCINELACTOBIONAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126741.pdf",
  "authorised_at": "2020/07/01",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126741//01800",
  "additional_monitoring": "N"
}

See everything about erythromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.